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Abstract
Background: Lymphomatosis cerebri (LC) is a rare subtype of primary central nervous system malignant lymphoma.
The typical features of this disease exhibited on magnetic resonance imaging (MRI) without contrast enhancement are
similar to those observed with diffuse leukoencephalopathy, mimicking white matter disorders such as encephalitis.
Clinical features and examination findings that are suggestive of inflammatory diseases may indeed confound the
diagnosis of LC.
Case presentation: A 66-year-old woman with continuous fever over a two-month period developed left hemiparesis
despite presenting in an alert state with normal cognitive function. Sampling tests showed autoantibodies in the
serum and inflammatory changes in the cerebrospinal fluid. The results from an MRI demonstrated multiple non-
enhanced brain lesions in the splenium of the corpus callosum and deep white matter. Single photon emission
computed tomography revealed increases in blood flow in the basal ganglia, thalamus and brainstem. No systemic
malignancies were found. The patient was suspected of having a diagnosis of nonvasculitic autoimmune inflammatory
meningoencephalitis and treated with intravenous methylprednisolone pulse therapy. Her fever transiently dropped to
within the normal range. However, she had a sudden seizure and a second MRI exhibited infiltrative lesions gradually
extending throughout the whole brain. We performed a brain biopsy, and LC was histologically diagnosed. The patient
received whole-brain radiation therapy, which diminished the fever and seizures. The patient died one year after the
initial onset of fever.
Conclusions: The present case yields an important consideration that brain neoplasms, especially LC, cannot be
ruled out, even in cases with clinical characteristics and examinations consistent with inflammatory diseases.
Careful follow-up and histological study are vital for the correct diagnosis of LC.
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Background
Primary central nervous system malignant lymphoma
(PCNSL) generally forms either a single or multiple iso-
lated, solitary mass lesions in the brain parenchyma. A
very rare PCNSL variant, known as lymphomatosis cere-
bri (LC), presents as the diffuse infiltration of lymphoma
cells in gray and white matter without the formation of a
cohesive tumor mass [1, 2]. In this study, we report the
case of a patient with continuous fever and multiple
brain lesions. Because the patient had autoantibodies
with no positive findings of malignancy, she was initially
suspected of having a diagnosis of nonvasculitic auto-
immune inflammatory meningoencephalitis (NAIM).
Because extensive immunotherapy failed to result in
symptomatic improvements, we performed a brain bi-
opsy, which revealed diffuse infiltration of lymphoma
cells in the brain parenchyma. Thus, a diagnosis of LC
was made. We showed that LC could follow a clinical
* Correspondence: takebou@fmu.ac.jp
1Department of Neurology, Fukushima Medical University, 1, Hikarigaoka,
Fukushima 960-1295, Japan
2Advanced Clinical Research Center, Fukushima Global Medical Science
Center, Fukushima Medical University, 1, Hikarigaoka, Fukushima 960-1295,
Japan
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Murakami et al. BMC Neurology  (2016) 16:128 
DOI 10.1186/s12883-016-0655-7
course mimicking inflammatory disease and that careful
attention was required to distinguish LC from inflamma-
tory diseases.
Case presentation
A 66-year-old woman, who had been healthy with no
relevant previous medical history, complained of con-
tinuous fever starting two months before initial presen-
tation. She realized weakness on her left extremities and
was admitted to a city hospital for evaluation of fever
and left hemiparesis. Then, she was transferred to our
hospital for further evaluation three weeks later. On
examination, her general condition was normal, except
for an elevated body temperature (38.0° Celsius). No
lymph-nodes were palpable. Additionally, she did not
complain of Sicca symptoms, night sweats or weight
loss. The patient was alert and had normal cognitive
function. She had left hemiparesis (grade 4 as measured
by the Manual Muscle Strength Testing) with bilat-
eral brisk deep tendon reflexes and extensor plantar
responses. Sensory extinction was noted in her left
extremities.
The blood sample tests showed a slightly elevated C-
reactive protein level (0.68 mg/dl) and erythrocyte
sedimentation rate (17 mm/h) as well as a high titer of
antinuclear antibodies (x1280, speckled pattern). Anti-
SS-A and anti-Ro52 antibodies were positive but anti-
SS-B antibody was negative. Lip biopsy showed no in-
flammation. Immunoblotting revealed IgG-k monoclonal
gammopathy; however, bone marrow histology showed
10 % proliferation of clonal plasma cells without light
chain restriction, and Bence-Jones protein was not found.
Tumor markers were negative and soluble interleukin-2
receptor (sIL-2R) was within the normal range. Cerebro-
spinal fluid (CSF) showed slight pleocytosis (11/μl; mature
lymphocyte 94 %, no atypical cells). However, normal
ranges of glucose and protein levels (73 mg/dl and 26 mg/
dl, respectively) were observed. We also observed incre-
ments of both the IgG index (1.26) and interleukin 6
(29.4 pg/ml) but no increment of sIL-2R.
Brain magnetic resonance imaging (MRI) exhibited hy-
perintense signals in the splenium of the corpus callo-
sum and right-hemisphere dominant deep subcortical
white matter without contrast enhancements (Fig. 1a-c).
The brain lesions showed normal concentration patterns
of choline, creatine and N-acetyl aspartate using MR
spectroscopy. However, 123I-IMP single photon emission
computed tomography (SPECT) demonstrated blood
flow increases in the basal ganglia, thalamus and
brainstem (Fig. 1d), and 201Tl-scintigraphy revealed no
abnormal accumulation in any part of the brain. 67Ga-
scintigraphy found no evidence of systemic malignancy.
Fig. 1 Brain magnetic resonance images and single photon emission computed tomography (SPECT). a-c Two months after fever onset,
fluid-attenuated inversion recovery (FLAIR) images show diffuse high signal intensity in the splenium of the corpus callosum and right-hemisphere
dominant subcortical white matters. However, this finding is (a) neither exhibited in the temporal lobes nor exhibited in the brainstem (c). No contrast
enhanced lesions are observed in gadolinium-enhanced T1-weighted images (b). d SPECT study shows hyperperfusion in the basal ganglia, thalamus
and brainstem. (E-H) Axial FLAIR images. Approximately five months after the onset of fever, hyperintensity lesions extended to the frontotemporal
lobes, bilaterally (e, f). Twelve months after the onset of fever, FLAIR images show diffuse progression of infiltrative lesions in the whole brain including
the brainstem with systemic brain atrophy (g, h)
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We tentatively diagnosed the patient as having NAIM
associated with anti-SS-A and anti-Ro52 antibodies, as
well as monoclonal gammopathy of undetermined sig-
nificance. She was treated with intravenous methylpred-
nisolone (mPSL) pulse therapy (1 g during the course of
three days) and her fever transiently ceased. Three
months after the onset of fever, she suddenly developed
generalized tonic-clonic seizures (GTCS), which remained
uncontrolled after the administration of antiepileptic med-
ications. Intravenous immunoglobulin (IVIG) (0.4 g/kg in
five days) had no beneficial effects. A second brain MRI
showed extensive lesions that had developed in the bilat-
eral frontotemporal lobes (Fig. 1e, f ).
Brain specimens were sampled from the right frontal
lobe using a brain biopsy. The histopathological examin-
ation showed atypical lymphoid cells with enlarged
round nuclei diffusely infiltrating the cortical gray and
subcortical white matters. These atypical cells were not
cohesive, nor did they form a mass lesion. Perivascular
tumor-cell cuffing was partly observed but not conspicu-
ous. No necrosis was present, and mitotic figures were
scant in number. Atypical cells were strongly labeled by
antibodies for CD20, a B-cell marker. Additional
immnunohistochemical studies revealed that tissue was
positive for BCL-2, BCL-6 and MUM-1 but negative for
CD5 and CD10 (Fig. 2a-i). A diagnosis of LC variant of
diffuse large B-cell lymphoma, non-germinal center B-
cell pattern was made based on these histopathological
and immunohistochemical features.
The patient had repeated GTCS, and accompanying
severe aspiration pneumonia. She needed antibiotics and
mechanical ventilator support. Considering the patient’s
exhausted condition, we and her family chose to perform
whole-brain radiation therapy (total 30 Gy) but not
high-dose chemotherapy or rituximab therapy because
the main adverse effect, bone marrow suppression,
Fig. 2 Pathological findings of brain biopsy. a-c Hematoxylin-eosin staining revealed diffuse infiltration of atypical cells in cortical gray (a, b) and
deep white matter (c). Lymphoma cells show enlarged round nuclei, thin cytoplasmic rims and occasional nucleoli (arrowheads). Mitotic cells
(arrow) and reactive astrocytes with eosinophilic cytoplasm (asterisk) are identified (b). Perivascular infiltration of the atypical cells was partly
observed (d). Immunohistochemical studies revealed the infiltration of CD20 positive cells in the parenchyma (e, f) and numerous MIB-1 positive
cells (g). BCL-6 and MUM-1 immnunostainings highlight a non-germinal center B-cell pattern (h, i)
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might be critical for her prognosis. Fever and seizures
ceased for two months during and after the radiation
therapy; however, she never regained consciousness. The
follow-up MRIs revealed the progression of the lesions
throughout the whole brain accompanying diffuse brain
atrophy (Fig. 1g, h). She died one year after the initial
onset of fever. No autopsy was permitted.
Conclusions
Unlike nodular lesions with contrast enhancement of
PCNSL [3, 4], MRI findings of LC are generally consist-
ent with diffuse leukoencephalopathy with absent or
very faint patchy contrast enhancement, mimicking
various white matter disorders [1, 2]. Therefore, diagnos-
ing LC is a difficult challenge and cannot be accom-
plished using conventional MRI alone. Pathological
examination is crucial for making an accurate diagnosis.
Pathological examination should show diffuse infiltration
of lymphoma cells in the parenchyma without resulting
tissue destruction. Furthermore, lack of contrast en-
hancement in MRI and no destroyed vessels in the
histopathological study are assumed to reflect an intact
blood–brain barrier [1].
Previous reports of LC have shown several clinical
features of this disease, such as subacute progressive
dementia, personality changes, unsteady gait and epilep-
tic seizures [5–7]: however, to the best of our knowledge,
LC in patients with continuous fever has not been
reported to date [3, 8].
In the present case, we first suspected NAIM based on
findings that were suggestive of an inflammatory disease,
such as the existence of autoantibodies with inflamma-
tory CSF changes, multiple non-enhanced brain lesions
on MRI and the transient improvement experienced
after the initial mPSL treatment. NAIM is characterized
as a steroid-responsive encephalopathy associated with
nonspecific autoantibodies [9]. In steroid-resistant cases
of NAIM, the use of IVIG results in a sufficiently good
outcome [10]. In our case, however, the resistance to the
subsequent immunotherapy led us to perform the brain
biopsy, from which we were able to make a diagnosis of
LC. A transient benefit from the mPSL may be explained
by the reduction of the lymphocytotoxic effects.
Although there are no detectable lesions observed
during the first experimental MRI, hyperperfusion
lesions present in the basal ganglia, thalamus and brain-
stem, which were observed during the SPECT, might
reflect infiltration of LC, indicating that the continuous
fever may be explained by dysfunction of thermoregula-
tion in the hypothalamus.
The prognosis of LC is generally considered to be
poorer than that of PCNSL, and most LC patients are
reported as dying within six months of the initial onset
[5, 11]. In contrast, some recent LC cases diagnosed at
early stages by pathological examination responded
favorably to appropriate treatments [12, 13]. Therefore,
early pathological diagnosis should be undertaken in
patients suspected of having LC.
In patients with atypical presentations exhibiting
features of NAIM, neoplastic disorders of the brain,
especially LC, should be considered. Careful follow-up
and timely tissue diagnosis are important to determine
specific treatments and interventions.
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